Costs and Consequences of Clopidogrel versus Aspirin for Secondary Prevention of Ischaemic Events in (High-Risk) Atherosclerotic Patients in Sweden: A Lifetime Model Based on the CAPRIE Trial and High-Risk CAPRIE Subpopulations

Author: Logman J. Floris S.  

Publisher: Adis International

ISSN: 1175-5652

Source: Applied Health Economics and Health Policy, Vol.8, Iss.4, 2010-07, pp. : 251-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract